Business Description
Nexien BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US46116E1038
Description
Nexien BioPharma Inc is a researcher and developer of cannabinoid-based pharmaceutical for various medical conditions and disorders, all under U.S. Food and Drug Administration development pathways.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | -104.67 | |||||
| Debt-to-Equity | -0.75 | |||||
| Debt-to-EBITDA | -1.12 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 53.6 | |||||
| 3-Year EPS without NRI Growth Rate | 41.1 | |||||
| 3-Year FCF Growth Rate | 30.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.42 | |||||
| 9-Day RSI | 44.08 | |||||
| 14-Day RSI | 45.93 | |||||
| 6-1 Month Momentum % | -35.95 | |||||
| 12-1 Month Momentum % | -45.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.01 | |||||
| Quick Ratio | 0.01 | |||||
| Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.8 | |||||
| Shareholder Yield % | -2.3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -10.43 | |||||
| EV-to-EBITDA | -10.43 | |||||
| EV-to-FCF | -33.18 | |||||
| Earnings Yield (Greenblatt) % | -9.59 | |||||
| FCF Yield % | -6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NXEN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nexien BioPharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.008 | ||
| Beta | -0.64 | ||
| Volatility % | 84.42 | ||
| 14-Day RSI | 45.93 | ||
| 14-Day ATR ($) | 0.006426 | ||
| 20-Day SMA ($) | 0.021729 | ||
| 12-1 Month Momentum % | -45.67 | ||
| 52-Week Range ($) | 0.011 - 0.0998 | ||
| Shares Outstanding (Mil) | 67.47 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nexien BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nexien BioPharma Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Nexien BioPharma Inc Frequently Asked Questions
What is Nexien BioPharma Inc(NXEN)'s stock price today?
The current price of NXEN is $0.02. The 52 week high of NXEN is $0.10 and 52 week low is $0.01.
When is next earnings date of Nexien BioPharma Inc(NXEN)?
The next earnings date of Nexien BioPharma Inc(NXEN) is .
Does Nexien BioPharma Inc(NXEN) pay dividends? If so, how much?
Nexien BioPharma Inc(NXEN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers